Medifast Statistics
Total Valuation
Medifast has a market cap or net worth of $180.23 million. The enterprise value is $27.90 million.
| Market Cap | 180.23M |
| Enterprise Value | 27.90M |
Important Dates
The last earnings date was Monday, November 4, 2024, after market close.
| Earnings Date | Nov 4, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Medifast has 10.65 million shares outstanding. The number of shares has increased by 0.03% in one year.
| Current Share Class | 10.65M |
| Shares Outstanding | 10.65M |
| Shares Change (YoY) | +0.03% |
| Shares Change (QoQ) | +0.31% |
| Owned by Insiders (%) | 2.34% |
| Owned by Institutions (%) | 79.59% |
| Float | 9.40M |
Valuation Ratios
The trailing PE ratio is 25.42.
| PE Ratio | 25.42 |
| Forward PE | n/a |
| PS Ratio | 0.27 |
| Forward PS | 0.35 |
| PB Ratio | 0.87 |
| P/TBV Ratio | 0.87 |
| P/FCF Ratio | 5.33 |
| P/OCF Ratio | 4.51 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 1.03, with an EV/FCF ratio of 0.82.
| EV / Earnings | 3.81 |
| EV / Sales | 0.04 |
| EV / EBITDA | 1.03 |
| EV / EBIT | 1.19 |
| EV / FCF | 0.82 |
Financial Position
The company has a current ratio of 3.11, with a Debt / Equity ratio of 0.09.
| Current Ratio | 3.11 |
| Quick Ratio | 2.35 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 0.55 |
| Debt / FCF | 0.52 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 3.66% and return on invested capital (ROIC) is 6.63%.
| Return on Equity (ROE) | 3.66% |
| Return on Assets (ROA) | 4.77% |
| Return on Capital (ROIC) | 6.63% |
| Revenue Per Employee | $1.06M |
| Profits Per Employee | $11,554 |
| Employee Count | 634 |
| Asset Turnover | 2.21 |
| Inventory Turnover | 3.59 |
Taxes
In the past 12 months, Medifast has paid $4.99 million in taxes.
| Income Tax | 4.99M |
| Effective Tax Rate | 40.51% |
Stock Price Statistics
The stock price has decreased by -74.74% in the last 52 weeks. The beta is 1.17, so Medifast's price volatility has been higher than the market average.
| Beta (5Y) | 1.17 |
| 52-Week Price Change | -74.74% |
| 50-Day Moving Average | 18.72 |
| 200-Day Moving Average | 22.71 |
| Relative Strength Index (RSI) | 36.00 |
| Average Volume (20 Days) | 246,010 |
Short Selling Information
The latest short interest is 1.62 million, so 15.22% of the outstanding shares have been sold short.
| Short Interest | 1.62M |
| Short Previous Month | 1.65M |
| Short % of Shares Out | 15.22% |
| Short % of Float | 17.25% |
| Short Ratio (days to cover) | 7.68 |
Income Statement
In the last 12 months, Medifast had revenue of $674.48 million and earned $7.33 million in profits. Earnings per share was $0.67.
| Revenue | 674.48M |
| Gross Profit | 497.77M |
| Operating Income | 23.35M |
| Pretax Income | 37.29M |
| Net Income | 7.33M |
| EBITDA | 27.03M |
| EBIT | 23.35M |
| Earnings Per Share (EPS) | $0.67 |
Balance Sheet
The company has $169.96 million in cash and $17.63 million in debt, giving a net cash position of $152.33 million or $14.30 per share.
| Cash & Cash Equivalents | 169.96M |
| Total Debt | 17.63M |
| Net Cash | 152.33M |
| Net Cash Per Share | $14.30 |
| Equity (Book Value) | 207.34M |
| Book Value Per Share | 19.47 |
| Working Capital | 152.60M |
Cash Flow
In the last 12 months, operating cash flow was $39.95 million and capital expenditures -$6.12 million, giving a free cash flow of $33.83 million.
| Operating Cash Flow | 39.95M |
| Capital Expenditures | -6.12M |
| Free Cash Flow | 33.83M |
| FCF Per Share | $3.18 |
Margins
Gross margin is 73.80%, with operating and profit margins of 3.46% and 1.09%.
| Gross Margin | 73.80% |
| Operating Margin | 3.46% |
| Pretax Margin | 1.83% |
| Profit Margin | 1.09% |
| EBITDA Margin | 4.01% |
| EBIT Margin | 3.46% |
| FCF Margin | 5.02% |
Dividends & Yields
Medifast does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.03% |
| Shareholder Yield | -0.03% |
| Earnings Yield | 4.06% |
| FCF Yield | 18.77% |
Analyst Forecast
The average price target for Medifast is $17.00, which is 0.47% higher than the current price. The consensus rating is "Hold".
| Price Target | $17.00 |
| Price Target Difference | 0.47% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Medifast has an Altman Z-Score of 7.2 and a Piotroski F-Score of 6.
| Altman Z-Score | 7.2 |
| Piotroski F-Score | 6 |